
QSP—rebuilt for scale. Certara IQ™ removes QSP bottlenecks with pre-validated models, AI-guided workflows, and secure cloud collaboration—so teams move faster with confidence. Request a demo: ow.ly/QgUi50Y0e59 #CertaraIQ #QSP #MIDD

Accelerating medicines to patients with biosimulation, technology and services.

QSP—rebuilt for scale. Certara IQ™ removes QSP bottlenecks with pre-validated models, AI-guided workflows, and secure cloud collaboration—so teams move faster with confidence. Request a demo: ow.ly/QgUi50Y0e59 #CertaraIQ #QSP #MIDD

With Certara IQ™, one QSP platform supports EFA, FIH, and RP2D—connecting mechanism, PK/PD, and disease biology to move faster with confidence. Request a demo: ow.ly/QgUi50Y0e59 #CertaraIQ #QSP #MIDD


With Certara IQ™, one QSP platform supports EFA, FIH, and RP2D—connecting mechanism, PK/PD, and disease biology to move faster with confidence. Request a demo: ow.ly/QgUi50Y0e59 #CertaraIQ #QSP #MIDD

🚀Big news from Certara at #BIOInternational 2026! Launching 𝗕𝗶𝗼 𝗩𝗲𝗻𝘁𝘂𝗿𝗲 𝗖𝗮𝘁𝗮𝗹𝘆𝘀𝘁 to boost emerging biotech success. Learn more: certara.com/services/bio-ven…

Pregnant women are excluded from drug trials, leaving critical treatment gaps. In a new interview in The Medicine Maker, Karen Rowland Yeo explains how PBPK modeling can fill the evidence gaps that clinical trials alone cannot: themedicinemaker.com/issues/… #WomensHealth

Pregnant women are excluded from drug trials, leaving critical treatment gaps. In a new interview in The Medicine Maker, Karen Rowland Yeo explains how PBPK modeling can fill the evidence gaps that clinical trials alone cannot: themedicinemaker.com/issues/… #WomensHealth


We're excited to welcome Akiko Watanabe to Certainty Japan 2026! Join her session on PBPK in DDI evaluation. 𝗗𝗮𝘁𝗲 𝗝𝗨𝗡𝗘 𝟮𝟯, 𝟮𝟬𝟮𝟲. Register: ow.ly/4VPs50Z6F7E #CertaintyAPAC2026 #MIDD #M&S #Certara

This #PrideMonth, Certara honors the LGBTQ+ community's impact on clinical research and drug development. Happy Pride 🌈

Join our session to see Phoenix WinNonlin and complementary tools working together in Phoenix Cloud and discover how to simplify your daily workflow. Register today: ow.ly/ylbG50Z4bbU

Scaling QSP starts with the right platform. Certara IQ™ is an AI-enabled, cloud-based solution to standardize models, accelerate development, and run scalable simulations. See it live at our Global Roadshow: ow.ly/jcBw50Yij1A #CertaraIQ #QSP

The EMA launches a pilot for Model-Informed Drug Development, advancing ICH M15 guideline adoption. Watch the webinar: ow.ly/A6If50Z12Mn #EMA #MIDD #ICHM15 #Pharmacometrics #PBPK #QSP #MBMA #DrugDevelopment

Can plasma biomarkers replace PET scans in Alzheimer's trials? New QSP study reveals key insights on treatment response, biomarker impact, and patient benefits. Read more: ow.ly/c2ps50YYplN #Alzheimers #QSP #Biomarkers #ClinicalTrials #MIDD

Join Certara's experts May 21, 11 AM ET for a webinar on minimizing risk in Hepatic Impairment studies. Register: ow.ly/nsb350YYnOY #DrugDevelopment #PBPK #Pharmacometrics #MIDD #ClinicalResearch

A new U.S. Executive Order boosts psychedelic therapy momentum—what does it mean for researchers and compliance? Read more: ow.ly/gRQ050YXPV8 #Psychedelics #DrugDiscovery #FDA #ControlledSubstances #ComplianceChecker